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In order to study a previously described genetic difference manifested in stem cell 
kinetics of specific mouse strains, effects of this putative gene, stk, were measured 
on growth and expansion of stem and progenitor cell populations ex vivo. Bone 
marrow cells from each of two inbred mouse strains, C57BL/6J and DBA/2J, were 
placed into separate bioreactor cultures perfused continuously with growth me- 
dium containing erythropoietin (Epo), interleukin-3 (IL-3), granulocyte-macrphage 
colony stimulating factor (GM-CSF), and Kit ligand as well as 5% CO,. Expansion 
of cell numbers reached 20-fold for DBARJ and 10-fold for C57BL/6J marrow 
within about 1 week of culture. Significant production was also seen of colony- 
forming unit (CFU)-GM (up nine-fold from input levels) just prior to the cell 
production peak, and, importantly, moderate expansion of day 12 colony-form- 
ing unit-spleen (CFU-S; two- to threefold) occurred as well, although CFU-S 
production peaked at a relatively short 4 days. CFU-S and CFU-GM levels de- 
clined rapidly in culture, either because of unfavorable growth conditions or 
terminal differentiation. Attempts to remove toxic metabolites by increasing the 
media perfusion rate resulted in a boost in cell expansion capability by DBARJ 
marrow. In bioreactors in which stromal cells were established before marrow 
inoculation, there was greater expansion of CFU-S (especially by DBARJ) and 
CFU-GM, although total cell yield appeared to be unaffected, perhaps because 
the maximum cell density had already been reached. The relative high potential 
for CFU-S expansion measured in DBA/2J marrow over that of C57BL/6J will be 
useful in following genetic contributions to bone marrow production capacity. 
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Hematopoietic stem cells stand at  the top of the blood 
developmental hierarchy and possess the developmen- 
tal potential to supply at least eight lineages of mature 
blood cells (Metcalf, 1988). While these cells are 
thought to be critical for engraftment of myelo-ablated 
recipients, much more needs to be known about how 
stem cell self-renewal and differentiation are regu- 
lated, both at  the molecular and genetic levels. Our 
purpose in undertaking these studies was to identify 
stem cell attributes under genetic control and to exploit 
these to identify and characterize genes responsible for 
phenotypes significantly affecting their function. The 
specific phenotype studied in this case was the stem 
cells’ ability to maintain high levels of mature he- 
matopoietic cell output in vitro and to expand popula- 
tions of primitive cells at the same time. 
Many groups have been studying the expansion of 
primitive hematopoietic progenitor cells in vitro for a 
number of years. Muench et al. (1993) have used inter- 
leukin (IL)-l and Kit ligand (KL) to expand murine 
bone marrow in short-term suspension cultures and re- 
ported a 200-fold enrichment in radioprotective ability. 
Work by Wineman et al. (1993) has shown that the 
maintenance of the most primitive bone marrow cells 
(for at least 3 weeks) is dependent upon their interac- 
tions with the underlying bone marrow stroma, and 
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that stromal cell lines differ in their abilities to support 
hematopoiesis. The successful employment of perfusion 
bioreactor systems for bone marrow by Caldwell et al. 
(1991) and Palsson et al. (1993) has identified and un- 
derappreciated problem in marrow culture; i.e., the 
buildup of toxic metabolites in the culture media with 
increasing cell density. Work by Reisbach et al. (1990) 
showed a positive correlation between IL-3-dependent 
proliferation and the production of lactic acid in murine 
hematopoietic cell lines. Blazsek et al. (1991) examined 
the effects of heliodynamic hormones on bone marrow 
metabolism and found that the inhibition of lactic acid 
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production correlated with terminal differentiation of 
hematopoietic progenitors. These studies imply that 
lactic acid buildup may be an  unwanted hallmark of 
high progenitor density. Our presently described stud- 
ies of in vitro marrow metabolism seem to confirm this 
hypothesis. 
Little study as get has focused on the genetic contri- 
butions to hematopoietic ability either in vitro or in 
vivo. We previously showed a difference in cell cycling 
frequency of spleen colony-forming units (CFU-S; very 
immature progenitor cells) between the two inbred 
strains of mice studied here, C57BLi6 and DBA/2 (Van 
Zant et al., 1983). In the DBAI2 strain, about 20% of 
CFU-S were found to be in S-phase of the cell cycle, 
whereas in C57BL/6 fewer than 5% of CFU-S were in 
cycle. This observation suggested the existence of a 
gene (or genes), present in only one of the strains, 
which may control the kinetics of stem cell cycling. The 
unidentified genetic element was termed stk for stem 
cell kinetics. 
We have further studied this phenotype in C57BL/ 
6-DBAi2 allophenic mice (Van Zant et al., 1990). In 
such aggregated-embryo chimeras, stem cells of both 
strains are in competition with each other in the same 
animal. Since the bone marrow stroma was likewise 
chimeric, possible microenvironmental differences be- 
tween strains were negated and thus any functional 
differences were intrinsically regulated. The periph- 
eral blood of these animals was sampled and the rela- 
tive contribution of stem cells of each strain to the blood 
cell composition was determined at many time inter- 
vals. As these animals aged, the proportion of blood 
made up of DBA/2 cells slowly declined, until by 2 years 
of age no contribution could be seen by DBAI2 stem 
cells, and the blood appeared to be 100% of C57BL/6 
origin. Interestingly, DBA/2 cell production declined at 
about the natural DBAi2 lifespan (it is the shorter-lived 
strain of the two). The role of this genetic unit in aging 
processes is still unclear. However, after transplanting 
the aged chimeric marrow into an  irradiated recipient, 
DBA/2 cells reappeared in the peripheral blood and 
actually dominated blood cell output for a short time, 
after which they again disappeared and were super- 
seded by C57BL/6 cells. A subsequent marrow trans- 
plant into secondary recipients again demonstrated the 
quiescence, not extinction, of DBN2 stem cells. These 
findings demonstrated an  inherent, genetically con- 
trolled difference between stem cells of the two strains 
which was influencing the cells’ ability to contribute to 
blood cell production as well as long-term hematopoie- 
tic output. 
Recently, we showed that DBN2J mice have a 
smaller pool of WGA+tLin-Rh-123b stem cells relative 
to C57BL/6J, and that these mice also differ with re- 
spect to their recovery times from cytotoxic (5-fluorou- 
racil) injection (Phillips et al., 1992). In addition, we 
observed that in allophenic mice the DBN2J compo- 
nent of the blood increased more than that of C57BL/6J 
when the mice were injected with KL. We are now a t  a 
point where we may begin to isolate specific genetic 
elements which differ between these two strains and 
which may be responsible for specific phenotypes. In 
pursuing this work our primary goals were to ascertain 
whether the stk-controlled genetic differences observed 
in vivo translate into in vitro cell production, and 
whether this difference could be used as a phenotypic 
assay to allow the genetic mapping of the elements 
involved. 
Important to the goal of expanding primitive progen- 
itor cells is an  understanding of the physiology of these 
cells. Early perfusion cultures run by Schwartz et al. 
(1991) expanded maximally when the medium was per- 
fused continuously at the rate of a half bioreactor vol- 
ume per day. Work by Palsson et al. (1993), which 
sought to mimic the in vivo bone marrow environment 
in vitro, has shown that hematopoietic cell yields and 
progenitor expansion were dependent upon factors such 
as seeding density and oxygen concentration. In the 
present work, we employ a novel perfusion bioreactor 
system to culture stem cells from these two strains and 
to analyze their strain-specific hematopoietic growth 
kinetics in vitro. Through these studies, we have been 
able to design a working assay for the stk phenotype 
which paves the way for genetic and physical mapping. 
MATERIALS AND METHODS 
Animals 
Female C57BL/6J and DBA/2J mice were obtained 
from The Jackson Laboratory (Bar Harbor, ME) and 
maintained in a specific pathogen-free facility at the 
University of Michigan’s Unit for Laboratory Animal 
Medicine according to National Institutes of Health 
(NIH) guidelines. 
Cells 
Bone marrow cell suspensions were obtained by 
flushing the femora and tibiae with cold Iscove’s modi- 
fied Dulbecco’s medium (IMDM; Sigma, St. Louis, MO) 
containing 10% fetal bovine serum (FBS). At least 
three donor mice from each strain were sacrificed for 
each experiment. Cells were brought to a concentration 
of 3 million/ml in Dexter medium (80% IMDM, 10% 
FBS, 10% horse serum) containing hydrocortisone (0.1 
mM; Sigma), gentamicin sulfate (40pg/ml), murine 
IL-3 (3.75 ng/ml; R&D Systems, Minneapolis, MN), hu- 
man erythropoietin (Epo; 0.1 Uiml; Amgen, Thousand 
Oaks, CAI rat KL (10 ng/ml; Amgen, Thousand Oaks, 
CAI, and murine granulocyte-macrophage colony stim- 
ulating factor (GM-CSF; 5 ng/ml; R&D Systems). All 
growth factors used were from recombinant sources. 
Bone marrow perfusion cultures 
Details of these small-scale culture chambers de- 
signed for expansion of human bone marrow have been 
described (Palsson et al., 1993). Whole marrow cells 
were placed into specially designed bioreactor culture 
chambers (Aastrom Biosciences, Ann Arbor, MI) at 
3 x lo5 cells/cm2 growth area. The cells were incubated 
overnight at 37°C with perfusion of gas but not of 
growth medium. On the next day, a medium perfusion 
schedule was begun and continued until the culture 
was removed for analysis. The medium used was as  
noted above and was kept at 4°C until it was warmed to 
37°C immediately prior to infusion into the culture ves- 
sel. Continuous infusion was maintained by kdS model 
220 syringe pumps (Stoelting, Chicago, IL). Where cul- 
tures were perfused a t  a defined variable rate, a com- 
puter was used to adjust the syringe pump infusion rate 
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continuously according to the defined schedule. Three 
groups of cells were then harvested from the reactors: 
first, the medium (containing nonadherent cells) was 
aspirated from the reactor with a syringe. Second, the 
reactors were washed with IMDM and the wash me- 
dium was aspirated. Third, the remaining cells were 
removed with trypsin (Sigma) and subsequent washing 
with Dexter medium. The three cell fractions thus ob- 
tained were denoted as “nonadherent,” “loosely adher- 
ent,” and “adherent,” respectively. Cells were counted 
by hemocytometer and glucose and lactic acid levels 
were measured on a YSI model 2000 glucoseilactate 
analyzer (YSI, Yellow Springs, OH). 
Stromal establishments 
In cultures in which the stroma was established be- 
fore inoculation, whole bone marrow cells were isolated 
from syngeneic strains of mice and irradiated (20.0 Gy) 
in a Gammacell 137Cs blood irradiator. Three million of 
these cells were then placed into each bioreactor and 
the reactors were incubated for 4 days at 33°C. Dexter 
medium was completely changed once daily after the 
second day. On the fifth day, nonadherent cells were 
removed and discarded and the cultures were inocu- 
lated with a fresh suspension of bone marrow cells. 
Cell labeling 
Cells were divided into groups and stained with dif- 
ferent rat anti-mouse IgG antibodies against lineage- 
specific antigens: anti-Ly-1 (CD5; T cells, some B cells), 
anti-Ly-2 (CD8; T-cytotoxic, T-suppressor cells), anti- 
B220 (CD45R; B cells and precursors), anti-Gr-1 (RB6- 
8C5; granulocytes), anti-Mac-1 (MU70.15.11.5; mac- 
rophages), and anti-erythroid (TER119; erythrocyte 
precursors). Lineage-specific antibodies were directly 
conjugated to fluorescein. Phycoerythrin-conjugated 
rat anti-mouse Ly-GA/E antibody was added to specific 
samples. All antibodies were obtained from Pharmin- 
gen (San Diego, CA) except fluoresceinated anti-Mac-1 
(Boehringer Mannheim, Germany), and the TER119 
antibody (a gift of Dr. Tatsuo Kina). All incubations 
were for 20 min a t  4°C and washed in IMDM + 0.1% 
bovine serum albumin (BSA). 
Cell analysis 
Cells were analyzed on an unmodified FACS Van- 
tage instrument (Becton-Dickinson, San Jose, CA). 
Cells were stained with monoclonal antibodies conju- 
gated directly or indirectly to various fluorochromes, 
which were excited with either an  Ar laser at 488 nm 
(for fluorescein or phycoerythrin) or HeNe laser at 633 
nm (for allophycocyanin). The different fluorochromes 
(allowing for antibody identification) emitted light at 
different wavelengths (fluorescein at 525 nm, phyco- 
erythrin at 575 nm, allophycocyanin at 675 nm) which 
were detected by sensitive photodetectors placed be- 
hind a series of optical filters. At least 10,000 cells were 
analyzed for each data point. Data analysis was per- 
formed using LYSYS I1 software ( Becton-Dickinson). 
Methylcellulose assays 
Cells were plated in methylcellulose medium con- 
taining 0.8% methylcellulose (Methocel; Dow, Midland, 
MI), 30% FBS, 1% BSA, 0.1 mM (3-mercaptoethanol, 40 
kg/ml gentamicin sulfate, 3.75 ng/ml murine IL-3 
(R&D Systems), 5 ng/ml murine GM-CSF (R&D Sys- 
tems), and 1 U/ml human Epo (Amgen) in IMDM. All 
growth factors were from recombinant sources. Cells 
were incubated for 11 days before counting under a 
dissecting microscope. 
CFU-S assay 
Animals were exposed to total-body irradiation (10.0 
Gy in one dose) in a Gammacell-40 irradiator housing 
d ~ a 1 l ~ ~ C s  sources. Within 1 hr  after irradiation, mice 
were given a bone marrow transplant containing 1% of 
the total cells in pooled bioreactor fractions, so that 
fractional proportions were maintained. Mice were sub- 
sequently housed in a specific pathogen-free facility 
and sacrificed 12 days later. Spleens were removed and 
fixed in Carnoy’s solution (60% ethanol, 30% chloro- 
form, 10% acetic acid) overnight. Macroscopic spleen 
colonies were counted the following day. 
RESULTS 
Growth kinetics 
Whole bone marrow was removed from C57BLi6J in- 
bred mice and placed into culture in specially designed 
bioreactors (3 x lo5 cells/cm2). At specific time inter- 
vals, cultures were harvested, whereupon cells were 
counted and lactic acid levels were measured in the 
efflux medium. As shown in Figure lA, the cell number 
first declined by about 33% from the original 3 million 
cells, then began to rise rapidly during days 2-6. After 
day 6, the cell production slowed considerably, and total 
cell number began to decline after about day 8. Human 
marrow in these bioreactor cultures, by comparison, 
reaches a cell plateau at about day 14 (Koller et al., 
1993). This difference in growth kinetics may be linked 
to differences in cell cycling rates between mice and 
humans. 
Each time reactors were harvested, cells were plated 
in methylcellulose medium containing Epo, IL-3, and 
GM-CSF and day 11 colonies were counted. As shown in 
Figure lB, CFU-GM levels rose markedly but tran- 
siently, reaching a peak just prior to the total cell peak. 
This was anticipated since CFU-GM would be expected 
to give rise to many mature cells in the presence of high 
growth factor concentrations in these cultures. 
At various times, harvested cells were stained with 
antibodies against specific mature cell lineage antigens 
(macrophages, Mac-1; granulocytes, Gr-1, erythrocytes 
and progenitors, TER119; T cells, CD5; B cells, CD45R; 
T-cytotoxic cells, CD8), as well as the hematopoietic 
stem cell antigen Sca-1 (Ly-GA/E). Three trends 
emerged from these studies: the expansion of myeloid 
cells, the decline of lymphoid and erythroid cells, and 
the relative stability of progenitors recognized by the 
Sca-1 antibody. As depicted in Figure 2, numbers of 
myeloid cells co-expressing Gr-1 and Mac-1 antigens 
rose considerably during the first few days of culture, 
while lymphoid (CD5, CD8, CD45R) and erythroid 
(TER119) cells declined to insignificant levels. Cells 
positive for Sca-1 remained in about the same propor- 
tion throughout culture, indicating that perhaps 
Sca-l+ cells expand at about the same rate as the whole 
culture. 
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Fig. 1. A Bone marrow growth kinetics of C57BL/6J cultures in 
perfusion bioreactors. 0, nonadherent cells; W, adherent cells. Three 
million whole marrow cells were inoculated into the bioreactors on day 
0 and media perfusion was begun a day later. B: Expansion of 
CFU-GM in C57BLi6J bone marrow cultures. The three cell fractions 
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were obtained from the bioreactor vessels as described. At least three 
separate cultures contributed to each data point. Data shown are rep- 
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Fig. 2. Expression of various cell surface antigens on the cultured marrow cells. Note that levels of Gr-1 
and Mac-1 positive cells are greatly increased, and that many cells appear to be Gr-1-Mac-l double 
positive. Note that TER119 (erythroid) cells disappear in culture. Three separate cultures were used to 
provide cells for the measurements; at least 10,000 cells were analyzed for each data point. 
Numbers of primitive CFU-S rise transiently 
in culture 
At various times, 1% of total harvested cells were 
injected into lethally irradiated (10.0 Gy) recipient 
mice. Figure 3 shows the CFU-S per reactor for both 
C57BL/6J and DBAIBJ strains at several time points. 
While moderate expansion of CFU-S was seen early on 
(more than twofold), little CFU-S activity was found in 
longer-term cultures. Whether this decline is the result 
of progenitor cell death caused by suboptimal growth 
conditions or simply differentiation remains to be de- 
termined, but the large number of CFU-GM produced 
may indicate that the vast stem cell potential for differ- 
entiation may be able to accommodate the CFU-GM 
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Fig. 3. CFU-S expansion in bioreactor cultures. Hatched bars, 
C57BLi6J; shaded bars, DBNW. CFU-S appeared to rise transiently 
by about fourfold, then disappear in later cultures. Note the greater 
magnitude and duration of CFU-S expansion by DBAiW marrow. 
Asterisks denote statistically significant higher levels of CFU-S in 
DBN2J cultures a t  day 0 (Student’s t test; ***P < 0.001) and day 8 
(*P < 0.05). At least three cultures assayed in at  least five mice were 
used for each data point. 
expansion seen here with ease. Note that both the mag- 
nitude and duration of CFU-S production were higher 
in the DBA/2J cultures, relating back to the original 
studies on CFU-S cycling in these two strains (Van 
Zant et al., 1983). 
A rise in lactic acid levels correlates with a 
slowdown in cell growth 
After about day 4 of culture, lactic acid levels in the 
efflux medium began to  increase sharply, coinciding 
with the beginning of the period of the most rapid cell 
expansion (Fig. 4). There was also a corresponding 
sharp drop in glucose concentration, indicating that 
glucose was being metabolized anaerobically to lactic 
acid. When lactate levels rose above an apparent criti- 
cal level of 10 mmol/L in the efflux medium, cell expan- 
sion slowed and cell number soon declined, suggesting 
that lactic acid levels may limit cell expansion in vitro. 
It should be noted that lactate levels were measured in 
bioreactor effluent, and may be much higher in proxim- 
ity to the cell bed. Interestingly, when the molar 
changes in glucose and lactate were compared, it was 
found that the molar ratio of glucose consumed to lac- 
tate produced (influx vs. efflux media) was 1:l.g; nearly 
the 1:2 theoretical ratio for complete anaerobic metabo- 
lism. Why these cells appear to undego anaerobic me- 
tabolism is a mystery, but since the ratio never reached 
1:2, it is thought that a subset of the marrow cells (e.g., 
the stroma) may be utilizing molecular oxygen, while 
the myeloid cells (comprising the vast majority of total 
cells) are not (Caldwell et al., 1991). 
In order to test whether oxygen was actually being 
used by the cultures, experiments were run in which 
some cultures’ gas lines contained 40% 0, (and 5% CO,, 
Fig. 4. Levels of glucose and lactate in C57BL/6J bioreactor cultures. 
Circles, influx medium levels; squares, efflux medium levels; open 
symbols, lactate; closed symbols, glucose. Despite the perfusion of 
growth medium, lactate levels began to rise along with cell number 
and eventually halted growth of the culture. Note that the molar ratio 
of glucose consumed to lactate produced is nearly 1:2, indicating that 
the vast majority of these cells are utilizing glucose anaerobically, 
despite the perfusion of air through the cultures. Three cultures were 
analyzed three times (total of nine measurements) for each data point; 
error bars represent the standard deviation of the combined data. Data 
presented are representative of the results obtained in three individ- 
ual experiments. 
TABLE 1. Effect of different oxygen concentrations on cell expansion1 
Millions of cells 
Adherent Nonadherent 
-~ 
- Percent oxygen 
(Sealed) 1.3 k 1.4 27.3 ? 5.4 
30.7 i 3.8 20 1.4 f 0.4 
40 1.6 f 0.4 32.6 i 5.2 
‘Oxygen concentration in the perfused gas does not seem to affect the total cell yield of 
these cultures, possibly because the cell number is already at its maximum dictated hy 
lactic acid levels. The increased oxygen tension did not affect levels of glucose and 
lactate in these cultures (data not shown). The following growth factors were added to 
each milliliter of culture medium: IL-3 (5 ng), GM-CSF (5 ng), Epo (0.1 U), and KL (10 
ng). Cultures were harvested at 8 days. 
balance: nitrogen), while others contained incubator 
air (21% 0,+5% COz). In addition, some cultures were 
run with the gas lines sealed, so that the only oxygen 
available was that in the chamber originally, plus the 
small amount dissolved in the warm medium. The cell 
yields of these three groups at  day 6 of culture are 
depicited in Table 1. While there appeared to be no 
significant detrimental effect of oxygen starvation on 
the cultures, they likewise showed no evidence of oxy- 
gen toxicity at 40% 0, and cell numbers may have even 
been increased slightly. Lactic acid production and glu- 
cose consumption were not significantly different 
among the three groups, supporting the idea that glu- 
cose was being metabolized anaerobically. Unexpect- 
edly, there were differences in progenitor numbers 
(Fig. 5). With perfusion of 40% 02, there was a 41% 
increase in numbers of CFU-GM, possibly because of 
metabolically favorable conditions for the stromal cells, 
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Fig. 5. Day 6 CFU-GM expansion in strain C57BLi6J a t  different 
oxygen tensions. Increased levels of oxygen in the perfused gas have a 
positive effect on CFU-GM colony expansion in all fractions. The as- 
terisk denotes that the total colony numbers at  40% oxygen were 
significantly greater (Student's t test; P < 0.05) than those of either 
the 0% or the 20% groups. Three separate cultures were used in each 
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which in turn had an impact on the hematopoietic cells 
close to them (the loosely adherent population). These 
data argue that molecular oxygen was indeed being 
consumed by the cultures, and that possibly an  energy 
source other than glucose was being metabolized aero- 
bically. 
Marrow cultured with a variable perfusion rate 
shows strain-specific growth kinetics 
In an effort to minimize the adverse effect of waste 
products such as  lactate on cell growth, the media per- 
fusion rate was increased smoothly (by computer) on a 
linear scale from 0.18 to 1.8 reactor volumes/day over 
the course of 1 week, so that the perfusion rate in- 
creased somewhat proportionally with cell number. 
Surprisingly, C57BL/6J marrow showed a minimal in- 
crease in hematopoietic output under the variable rate 
schedule, while output by DBA/2J marrow cultured un- 
der identical conditions almost doubled, so that the to- 
tal expansion of cells in DBAI2J cultures was almost 
20-fold by the 8th day of culture (Fig. 6). Additionally, 
the duration of cell growth in both cultures was ex- 
tended. The slowing of the growth rate at about the 8th 
day was accompanied again by rising lactate levels (lac- 
tate in the efflux media at day 8 was above 10 mmol/L, 
suggesting a limiting effect that lactic acid has on bone 
marrow expansion in vitro. 
Stromal cell growth correlates with higher 
progenitor concentrations 
Since the establishment of the stromal (adherent) 
layer in culture tended to mark the beginning of the 
burst of hematopoietic output, we attempted to induce a 
higher output rate by establishing stroma before inocu- 
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Fig. 6. Total nonadherent cell yield in variable-rate perfusion cul- 
tures of C57BL/6J (0 )  vs. DBNZJ (0). Adherent cells are denoted by U 
for C57BLJ6J and for DBAIZJ. DBAi2J cells outexpanded C57BLi6J 
two to one when the medium perfusion was increased to respond to the 
demands of cell mass. The medium perfusion rate was controlled by 
computer and followed a linear schedule, so that the rate had in- 
creased by 10-fold over the course of 1 week of culture. After the first 
week, the rate was held constant a t  8 mLiday (bioreactor volume is 4.5 
mL). At least three separate cultures contributed to each data point. 
days before inoculation, bioreactors were "seeded with 
irradiated (20 Gy) whole syngeneic marrow. At the 
time of inoculation, the nonadherent and loosely adher- 
ent fractions were removed, leaving a sparse monolayer 
of stromal cells. Whole syngeneic marrow was intro- 
duced onto this monolayer and expanded under the lin- 
ear rate schedule specified above for various lengths of 
time. 
Figure 7A shows the total cell yield of C57BLI6J and 
DBA/2J marrow in such cultures. While the presence of 
preformed stromal cells did not appear to affect the 
total cell yield of the cultures significantly, there was a 
positive effect on CFU-S support (Fig.7B) After 8 days 
on preformed stroma, CFU-S levels in DBA-2J cultures 
were about threefold higher than in the DBAI2J inocu- 
lum, and about fivefold higher than in the correspond- 
ing C57BL/6J culture. Given our earlier data on rela- 
tive cycling rates of CFU-S between C57BL/6J and 
DBAIBJ, this observation may lead to the development 
of a phenotypic assay for the effects of the stk gene. 
DISCUSSION 
Perfusion bioreactors were employed to culture 
whole bone marrow for 1-2 weeks and to identify the 
specific in vitro growth requirements of bone marrow 
cells in general and of hematopoietic stem cells in par- 
ticular. Using this novel system for culturing bone mar- 
row, we demonstrate expansion of total marrow cells by 
10- to 20-fold in 1 week, and increases in CFU-GM by 
about ninefold over levels in the inoculum. Moreover, 
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Fig. 7. A: Cell yields a t  day 8 of cultures grown on preformed synge- 
neic stroma. Black bars, adherent cells; shaded bars, nonadherent 
cells. Total cell yield did not differ significantly from those of control 
(nonpreformed stroma) cultures, possibly because the cell number had 
been limited by rising lactic acid levels. B: Expansion of CFU-S on 
preformed syngeneic stroma. Twelve-day CFU-S levels expanded in 
both cultures at day 8, but DBAiBJ showed higher absolute CFU-S 
the day 12 CFU-S population was found to expand by as 
much as threefold using this culture system. 
Compared with human bone marrow cultured in 
these bioreactors, our murine cultures show faster 
growth kinetics. Maximum cell density of about 3 
million/m2 (for C57BW6J;6 million for DBA/2J) was 
reached in about 7 days (Fig. lA), whereas in human 
cultures, maximum density (roughly 3 million/m2) 
takes twice as long (Koller et al., 1993). The growth 
kinetics of bone marrow cells are a complex function of 
many different cell types (and thus, growth require- 
ments) and culture conditions that are always in flux. 
Within 2 days of culture, we saw a general decline in 
cell number to about 30-60% of the inoculum, perhaps 
because apoptosis of specific cells was taking place due 
to a lack of uncharacterized essential growth factors 
(Koury, 1992; Williams et al., 1990; Yu et al., 19931, 
and because of the very limited lifespan of mature gran- 
ulocytes prevalent in the inoculum. This possibility 
was corroborated by flow cytometric evidence showing 
that a decline in cells bearing lymphoid and erythroid 
(despite the presence of Epo) surface antigens occurs 
very shortly after the beginning of culture (Fig. 2). Sim- 
ilar to observations in human cultures by Meagher et 
al. (1988) and Schwartz et al. (1991), levels of Gr-1 and 
Mac- 1 positive cells increased greatly, dominating the 
bioreactor output by 4 days of culture. This accumula- 
tion may be a direct effect of the presence of GM-CSF in 
the perfused medium, suggesting that culture condi- 
tions may be altered to generate desired cell composi- 
tions (Cormier et al., 1991; Dexter et al., 1990). A corre- 
sponding massive increase in CFU-GM numbers was 
















levels as well as  a higher (threefold) expansion rate. The asterisk 
denotes that CFU-S expansion (for DBAI2J cultures) was significantly 
greater (Student’s t test; P < 0.05) in the preformed stroma group than 
in cultures without preformed stroma or when compared to the inocu- 
lum. At least three cultures were used for each data point; three mice 
were used for each CFU-S assay. 
In order to investigate the dynamics of more primi- 
tive cells, we periodically injected 1% of the total reac- 
tor cells into lethally irradiated syngeneic mice to mea- 
sure CFU-SI2 levels. We found definite expansion of 
CFU-S early in the culture, but these cells appeared 
either to senesce or become deeply quiescent in older 
cultures. It is possible that a sufficient concentration of 
potent growth factors was present in the culture me- 
dium such that the CFU-S were stimulated to differen- 
tiate and were “used up.” Of equal likelihood is the 
possibility that a maximum concentration of he- 
matopoietic cells had been generated in these small 
cultures, and the buildup of toxic metabolites or other 
inhibitory factors had caused the CFU-S (and more 
primitive cells) to enter a deep cell cycle quiescence 
(Gophase) or maybe even killed them altogether. The 
fact that CFU-S did not appear in late-stage cultures 
means that they were unable to generate colonies when 
placed into an irradiated recipient animal in a bone 
marrow transplant; this implies that they were unable 
to reactivate and may be either dead or terminally dif- 
ferentiated. 
Bone marrow cultures tended to decline after about a 
week, and we investigated the corrigible limitations of 
long-term growth. Since lactic acid levels began to 
mount as the culture reached its growth peak, we at- 
tempted to reduce and remove lactic acid a) by adjust- 
ing the availability of molecular oxygen to the cell bed 
and b) by increasing the media perfusion rate to carry 
away such waste products. When the concentration of 
oxygen in the perfused gas was increased to 40%, the 
cultures showed no real increase in total cell yield (Ta- 
ble 1). Interestingly, none of the three groups of cul- 
tures (nonperfused, air only, or double oxygen concen- 
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tration) differed significantly in terms of cell yield, 
indicating that a) we found no evidence of oxygen toxic- 
ity in these cultures even at  40% oxygen, and b) the 
vast majority of these cells appear not to need oxygen 
perfusion, perhaps linked to the discovery that most of 
them are metabolizing glucose anaerobically. Another 
explanation for similar cell yields anlong the three 
groups may lie in the metabolic studies: glucose and 
lactate levels remained similar for the three groups as 
well, and it follows that buildup of lactic acid was inhib- 
iting further growth, so that the maximum culture size 
had been reached. In order to rule out glucose depriva- 
tion as  a reason for culture decline, we set up one group 
of cultures with 25 mM glucose in the medium (instead 
of the normal 20mM) and found that while glucose lev- 
els remained relatively higher, lactate production and 
culture longevity remained unaffected (data not 
shown). In oxygen-excess experiments, we were unsuc- 
cessful in our attempts to change the g1ucose:lactate 
molar ratio from approximately 1: 1.9, indicating that 
these cultures were receiving enough molecular oxygen 
to fit specific needs of the cells. When we measured 
CFU-GM levels among these groups, we found that 
higher oxygen concentrations resulted in higher 
CFU-GM output, in disagreement with data from cul- 
tured human marrow (Koller et al., 1992). Whether the 
CFU-GM population uses molecular oxygen or whether 
the supporting (stromal) cells are induced into a higher- 
output state by oxygen availability is unknown. In- 
creasing the perfusion rate resulted in significant gains 
in cell yield, but total glucose usage and lactic acid 
production remained unchanged, suggesting that 
mounting lactic acid levels may be a major cause of the 
decline of long-term cultures. In observing human bone 
marrow cultures, Meagher et al. (1988) have shown 
evidence that reactive oxygen intermediates generated 
by the accumulation of myeloid cells may also play a 
role in limiting progenitor expansion. 
In cultures in which a variable media perfusion rate 
was used, DBAI2J output exceeded by nearly twofold 
that of C57BW6J in parallel cultures. Since the same 
conditions were used for marrow culture in the two 
groups, our only conclusion can be that this difference 
arises from an  uncharacterized inherent difference be- 
tween bone marrow cells of these two strains. Likewise, 
CFU-GM and CFU-S expansion rates were different 
between these groups: DBM2J cultures consistently 
showed higher expansion rates of all cells measured. 
Given that previous data have shown a higher steady- 
state rate of CFU-S cycling in the DBAiW strain, it is of 
interest to note that the day 0 (steady-state in vivo) 
CFU-S levels were approximately twofold higher in 
DBAIBJ animals than in C57BL/6J (Table 2). Whether 
this observation by itself may account for all of the 
DBAiBJ productivity advantages seen in culture is un- 
known, but CFU-S expansion in DBAi2J cultures over 
that of C57BLi6J was greater (at later time points) 
than the twofold increase that might be expected from 
the steady-state CFU-S differences depicted in Table 1. 
While the steady-state CFU-S difference between these 
two strains may be only partially related to differences 
in hematopoietic output, this observation will nevethe- 
less become helpful in mapping the trait with recombi- 
nant inbred strains. The observation that DBAiBJ he- 
TABLE 2. Steady state in vivo levels of CFU-S in C57BLi6J and 
DBAi2J strains' 




22 19.4 i 3.3 
10 9.8 ? 2.6 
1.98:l 
'Mice were given a lethal dose of radiatmn (10.0 Gy) followed by a hone marrow 
transplant of 5 x lo4 fresh marrow cells Intravenously. Living mice were sacrificed 12 
days later and spleens were removed and fixed in Carnoy's solution overnight. Macro- 
scopic colonies were enumerated the next day. 
matopoietic output was greatly increased over that of 
C57BLi6J in these cultures is in agreement with our 
earlier in vivo data from allophenic mice (Van Zant et 
al., 1990; Phillips et al., 1992) indicating that DBAiBJ 
marrow, because of some inherent kinetic advantage, 
dominates competitive hematopoiesis in vivo and re- 
sponds faster to in vivo growth factor stimulation. If, as  
has been hypothesized, DBMBJ stem cells have a 
higher baseline rate of stem cell cycling, it seems logi- 
cal that there might be more CFU-S in the marrow to 
ensure that stem cell populations are never depleted in 
vivo. Though there may be little direct correlation be- 
tween total output and CFU-S cycling in these cultures, 
we have found differences in CFU-S expansion in cul- 
ture (Fig. 7) which may reflect the original observa- 
tions (Van Zant et al., 1983). 
When a stromal monolayer was allowed to grow be- 
fore marrow introduction, no real increase in cell yield 
was seen, possibly because the sizes of these culture are 
already being limited by lactate levels in later stages, 
but day 12 CFU-S numbers were significantly higher 
(Fig. 7). The fact that cultures grown on preformed 
stroma behaved differently from control cultures un- 
derscores the importance of stromal-stem cell intereac- 
tions in hematopoiesis. It has been shown that the bone 
marrow stroma is necessary for productivity of murine 
(Dexter e t  al., 1976; Wineman et al., 1993) as  well as  
human cultures (Koller et al., 19931, and we have evi- 
dence supporting earlier observations (Quesenberry et 
al., 1987) that the stromal microenvironment has a real 
effect on hematopoietic output in this system. It seems 
likely that the stromal remains a complex source of 
undiscovered cytokines or other factors acting at once 
positively and negatively on stem cells to give the en- 
tire hematopoietic system its considerable dynamic 
range (Daniel et al., 1989). Established stromal cell 
lines have been found to differ significantly in levels of 
hematopoietic support (Wineman et al., 1993), and we 
are investigating the use of these in optimizing the 
expansion of stem cells from fresh bone marrow. 
The characterization of the genetic elements in- 
volved in this differential bone marrow growth will be 
helpful in bone marrow transplantation and in gene 
therapy. Probes of patient cells for the human stk homo- 
logue may be used to evaluate transplant prognosis or 
to indicate what sorts of adjunct therapy may be re- 
quired to ensure transplant success in "slow kinetics" 
patients. The introduction of a "fast kinetics" gene into 
hematopoietic cells to be used in gene therapies may 
provide the level of competitiveness necessary so that 
the therapeutic gene is expressed by a sufficient num- 
ber of cells. Our finding that CFU-S numbers increased 
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in DBAiBJ cultures a t  a greater rate and to greater 
numbers than corresponding C57BL/6J cultures indi- 
cates that the original observations of stk phenotype in 
vivo do indeed apply to in vitro hematopoiesis. Further- 
more, the results described herein allow for the design 
of a working in vitro assay for the stk phenotype, so that 
analysis of recombinant inbred (BXD) strains of mice 
and other fine genetic and physical mapping strategies 
may be undertaken. It is our objective to clone the 
genes involved in this phenotype and to identify the 
human stk homologues. 
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